-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Arcus Biosciences, Maintains $32 Price Target

Benzinga·03/02/2026 11:28:08
Listen to the news
HC Wainwright & Co. analyst Emily Bodnar reiterates Arcus Biosciences (NYSE:RCUS) with a Buy and maintains $32 price target.